Teplizumab
Information about Teplizumab
Teplizumab uses
Teplizumab is used in the treatment of type 1 diabetes mellitus.
How teplizumab works
Teplizumab is an antibody that partially blocks the immune system’s attack on insulin-producing cells of the pancreas. In this way, Teplizumab preserves insulin production and reduces the requirement for insulin therapy.
Common side effects of teplizumab
Lymphopenia, Rash, Decreased white blood cell count (lymphocytes), Headache
Available Medicine for Teplizumab
Expert advice for Teplizumab
- Tell your healthcare provider if you have recently received or are scheduled to receive a vaccine. Teplizumab may affect the efficacy of the vaccine.
- Inform the doctor if you are currently pregnant or planning a pregnancy or if you are breastfeeding.
- Inform your doctor about an active or chronic infection or symptoms.
- Your doctor may prescribe a few anti-nausea and pain-relieving medicines for the first few days of treatment to prevent symptoms such as headache, fever, muscle and joint pain, or nausea. These side effects are not commonly observed.
Frequently asked questions for Teplizumab
Teplizumab
Q. How frequently do I need to take this medicine?
You will receive this medicine once a day, continuously for 14 days.
Q. What if I miss a scheduled dose?
If you miss a scheduled dose, your doctor will continue your treatment on the next scheduled day. You will not receive 2 doses on the same day.
Q. How is this medicine given?
Teplizumab is given an injection through the vein in your arm by a healthcare provider. Do not self-administer.